• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Breast carcinoma-amplified sequence 1 (BCAS1)

ACP08856

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08856 Target NameBCAS1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-584aaMol Weight63.7kD
Protein LengthFull lengthPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO75363
Background Information
  • Uniprot Id

    O75363

  • Target Species

    Human

  • Target Name

    BCAS1

  • Target Full Name

    Breast carcinoma-amplified sequence 1

  • Target Function

    Required for myelination.

  • Target Subcellular Location

    Cytoplasm.

  • Target Tissue Specificity

    Highly expressed in the brain and, more specifically, in oligodendrocytes (at protein level). Expressed in the prostate, and at lower levels in testis, intestine and colon. Overexpressed in most breast cancer cell lines and down-regulated in some colorect

  • Target Research Area

    Others

  • Target Synonyms

    AIBC 1; AIBC1; Amplified and overexpressed in breast cancer; BCAS 1; BCAS1; BCAS1_HUMAN; Breast carcinoma amplified sequence 1; Breast carcinoma-amplified sequence 1; Novel amplified in breast cancer 1

Inquire Recombinant Human Breast carcinoma-amplified sequence 1 (BCAS1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification